Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
why? that's only a queston.... so i'm not kidding! not with spzi, i loost too mutch money in this shs!
i write the text below in german, it's to hard for me in english
short version - is it realistic that spzi will be 1 dollar??? or whats an realistic pps for spzi? think on the massive more shs.....
könnt ihr euch wirklich vorstellen, dass SPZI noch auf 1 dollar steigt, nachdem die anzahl der herausgegebenen aktien massiv erhöht wurde und nachdem der kurs auf dem tiefsten punkt bei 0.0001 stehen geblieben ist?
klar, momentan steigt die aktie und auch ich denke und hoffe, dass der pps noch rauf geht, aber ist es realistisch im cent bereich zu denken oder was ist ein realistischer pps den spzi erreichen könnte?
i'll send you a private mail...
i havent found a good chart of aqui. anyone can give me an link?
we need a financial report! marani is TRUE, alive and well! believe in this stock, believe in it!
we WILL get great news of hsxi! i'm sure about that!
i believe in this stock!
look at the last news: http://www.mm2group.net/news/112607Q1Results.pdf
my opinion: we will see a much better time!
it's nice to know!
my opinion - it will be rais!!!! i bought now other 3'000'000 shs
aight!
look only at the chart - looks nice!
the mmgp chartanalysis makes me very happy!
nice...
spooz run run run run
I HOPE IT TOO! i don't understand, whats wrong whats false...??? now on 0.0008 one month ago the pps was on 0.01
Company Upgrade: Introduces AQUAGOLD International to our Small Cap Portfolio
Mar 19, 2008 (M2 PRESSWIRE via COMTEX) -- International Stock Targets is a world renowned independent research firm, based in Johannesburg, South Africa. Along with walking investors through the whole life-cycle of many different equities, we have also partnered with the top independent research firms worldwide to provide our members with the best knowledge to make money. Click the link below to see a sample of a recent "Buy Recommendation" that was issued on a small-cap equity that we believe is positioned to out-perform their competitors. We highly recommend that all interested small-cap investors sign up to www.internationalstocktargets.com for a free 3 month subscription and contact one of our representatives toll free 1 866 657 3334 to get access to our "small-cap" stock pick of the year. On Tuesday, March 18th, 2008, AQUAGOLD International (PINKSHEETS: ONMC) had a news release that triggered our research mechanism sensors at International Stock Targets. We therefore have also added AQUAGOLD International to our Small Cap Portfolio, their recent market activity has made them a possible candidate for a full analytical research report, to see a sample of our newest report view this link.
http://www.internationalstocktargets.com/Jan_2007_Target_Report.pdf
Investors looking to get a free stock report on any equity they have in their portfolio are also asked to sign up to www.internationalstocktargets.com for a free 3 month subscription. It's easy, free, and no credit card is needed. Our analysts will supply free stock reports for any equity trading on the NYSE, NASDAQ, AMEX, TSX, TSX Venture and US Small-Cap Markets. Enjoy this limited time offer for free.
For future reports on AQUAGOLD International and other growth stocks sign up to www.internationalstocktargets.com for a 3 month trial subscription.
"We at international stock targets have made it our goal to partner with as many of the top research firms and analysts to provide you the investors top quality research. Becoming a member to www.internationalstocktargets.com will give you free access to many different investment reports including analysis of most of the companies you hold in your portfolio. See how working with us today can expand your net worth tomorrow," Stefen Gorgin CEO and Head Analyst International Stock Targets
This Tuesday during the last hour's session, AQUAGOLD International was trading up 2.90 percent with a volume over 1,500,000.
On Tuesday, March 18th, 2008, AQUAGOLD International and Chairman & CEO Manuel Da Silva announced the Appointment of Independent Registered Public Accounting Firm Retained to Audit Financials and prepare Company to Qualify for listing on OTCQX or AMEX.
AQUAGOLD International also announced that, effective March 18, 2008, they have retained Mendoza Berger & Company LLP as their CPA for purposes of completing audited financials. The objective is to provide our investors reliable and up-to-date financial information upon which to base their investment decisions relative to AQUAGOLD International.
About us:
International Stock Targets is a world renowned research firm, specializing in identifying undervalued growth companies and walking members through the life-cycle of an equity's most aggressive growth periods. IST has been honoured the "Best International Research Team Award" three years in a row, and has been praised in many of the top publications globally and is recognized for their research, accuracy and professionalism.
Information contained in this release was extracted from publicly available sources deemed reliable. This document may contain forward-looking statements, particularly as related to the business plans of the Companies, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company's expectations and estimates. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. International Stock Targets may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our web site or within our reports.
International Stock Targets may at some time effect transactions in the securities mentioned. Additional information is available upon request subject to duties of confidentiality. The report has been compiled for information purposes only and under no circumstances should be considered as a solicitation to buy or sell any securities or as investment advice. While the information contained herein has been obtained from sources we believe to be reliable, International Stock targets does not represent or warrant the accuracy or completeness of the report. Independent investment advice should be sought before relying on any research regarding a specific company. Risk factors and actual results may differ significantly from the information contained in the report. International Stock Targets have not received compensation for this coverage and is not affiliated with the Company mentioned in this report. Target Prices are based on our own proprietary methods and should not be considered as all-inclusive nor considered as price projections based on revenue or performance. We strongly advise seeking professional investment advice.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2008 M2 COMMUNICATIONS LTD
nice... now come on!!! strong buy
pps only down? something wrong or whats going on?
mmgp hit the bottom...
i've looked at older dates, it was never under 0.0025... hope people hope
let's see, what's up the next days. my opinion 100 % up
think positive!!! reverse splits aren't negativ... it can be positive!!!!!!
today we hit the 0.045!!!
my opinion: next news are important, pps would be rise up with good news.
look at the chart, 0.004 is the resistant line!
Businessnewsnow.us: FDA Approvals
A Twenty Year Celebration; Universal Healthcare, & Infant Protection Stock News
New York, NY, Feb 12, 2008 (M2 PRESSWIRE via COMTEX) -- HealthSonix, Inc. (OTC: HSXI); Thoratec Corporation (NASDAQ:THOR); BearingPoint, Inc. (NYSE:BE); VeriChip Corporation (NASDAQ: CHIP)
BusinessNewsNow is an affiliate of Stock Profiler.US, LLC.
Sign up Today for Your Free Stock and Updated News Subscription at http://www.stockprofiler.us Companies who want to broadcast their progress are welcome to contact Stockprofiler.US, LLC at 603-621-9420.
-------------------------------------------
HealthSonix, Inc. (OTC: HSXI)
HealthSonix, Inc. closed at $0.12 Monday, trading 176,025 shares.
Company News- February 11, 2008: HealthSonix Gives Green Light for Production of the enSonix Medical Device
HealthSonix Inc. (OTC: HSXI) (FRANKFURT: H7S) announced yesterday that it is has approved the final sample of its second generation enSonix medical device. Shipments of finished product are expected to commence in the second quarter.
The enSonix personal treatment device has been registered and cleared with the United States, Food and Drug Administration (FDA), and has been designated as a class1 device, the safest classification for medical devices. It has been indicated for pain reduction and muscle relaxation.
"With this new medical device, we offer our customers affordable, effective arthritis pain relief without side effects. Patients can use it in the comfort of their own homes. The enSonix therapy is especially effective when used in combination with the most popular pain relievers. There is an incremental therapeutic benefit when you combine therapies," said Dieter Doederlein, Vice President of Corporate Development. "Arthritis is still the number one cause of chronic pain in North America and the HealthSonix breakthrough medical technology is very timely as the population segment most susceptible to arthritis will double over the next 20 years." The sound pressure waves generated by the enSonix medical device are believed to work in three ways: they stimulate mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control theory of pain); they create an exercise effect in the muscles, which encourages the production and release of endorphins, the body's natural pain killers; and increase in blood circulation.
"Our objective is very clear; deliver as much product this year as we can to fulfill significant order back log that has been created over the past 12 months and to focus on development and expansion of distribution and sales channels for all of our consumer products," added Mr. Doederlein.
About HealthSonix, Inc.
HealthSonix, Inc. (OTC:HSXI)(FWB:H7S) is a publicly traded research oriented medical technology company that develops and markets medical devices and healthcare products for institutional and consumer use. The company's patent pending medical devices deliver sound pressure waves to the human body for relief of pain and other musculoskeletal conditions. The focus is on arthritis, athletic injuries and conditions where acute or chronic pain is the cardinal symptom.
More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
-------------------------------------------
Thoratec Corporation (NASDAQ:THOR)
Thoratec Corporation closed at $14.84 Monday, trading 507,700 shares.
Company News- February 12, 2008: Tenderfoot Incision Device, the First Incision Device Designed for Pediatric Blood Draws, Celebrates 20 Years of Proven Clinical Use
Tenderfoot , the first incision device developed for heel-stick blood draws from infants and children, announced earlier today they are celebrating two decades of proven clinical use. Tenderfoot was designed by International Technidyne Corporation (ITC), a subsidiary of Thoratec Corporation (NASDAQ:THOR). The device is a major technology advance that standardizes the process of obtaining blood from infant and pediatric patients making it safer, less traumatic and less painful than those done with traditional lancet devices.
Introduced in 1988, the patented Tenderfoot device, unlike traditional lancets that punctured nerve fibers causing bruising and creating a jagged incision, makes a gentle, sweeping arc incision above the level of sensitive nerve fibers using a surgical blade that results in a high-quality blood sample with significantly less pain and trauma. Once the blade is triggered, it permanently retracts into the device to eliminate accidental sticks.
"We're proud that Tenderfoot pioneered improved delivery of healthcare services for infants and toddlers setting today's global standards," said ITC president, Lawrence Cohen. "Today we're celebrating 20 years of proven clinical use and, despite the competition that comes with success, our continued position as market leader." Tenderfoot offers a complete line of four incision devices to cover all pediatric blood draw needs. It is available in four incision depths and corresponding lengths from micro-preemie through toddler (0.65mm, 0.85 mm, 1.00 mm and 2.00 mm).
About ITC
ITC is a wholly-owned subsidiary of Thoratec and is a world leader in the fields of hemostasis management and point-of-care testing with over 35 years of knowledge and experience. ITC develops, manufactures and markets products in six distinct categories: HEMOCHRON point-of-care coagulation instruments and reagents; IRMA TRUpoint Blood Analysis System for blood gas and electrolyte testing; AVOXimeter co-oximetry devices and cuvettes; skin incision products including Tenderfoot , Tenderlett and Surgicutt ; Hgb Pro Professional Hemoglobin Testing System ; and the ProTime Microcoagulation System for prothrombin time testing at home and for professional use.
-------------------------------------------
BearingPoint, Inc. (NYSE:BE)
BearingPoint, Inc. closed at $1.96 Monday, trading 2,397,700 shares.
Company News- February 12, 2008: BearingPoint Predicts Rapid Expansion of Health Savings Accounts if Universal Health Coverage Programs are Adopted
BearingPoint, Inc. (NYSE:BE), one of the world's largest management and technology consulting firms, earlier today released projections for the impact of the most widely touted health proposal across the presidential candidates' platforms - universal coverage - on multiple health constituents. Universal coverage as described in the presidential health platforms, is being applied in California and Massachusetts and requires coverage for all (or nearly all) residents through mandates or incentives, for insurance usually supplied through employers of all sizes. In application, this would increase the offering of high-deductible health plans (HDHPs) and their associated financial accounts. According to BearingPoint's forecast, the implementation of universal healthcare in the U.S. could further impact all health constituents, including increasing HSA projections beyond the current 2012 estimates of more than 20 million new accounts with more than $200 billion in assets.
Many of the presidential candidates are currently discussing the possibility of universal health coverage programs in some form. Most are mentioning plans that may parallel the state initiatives in California and Massachusetts, wherein the employer is required to offer coverage or pay into a pool for employees to secure such coverage. BearingPoint believes that this type of initiative would increase adoption of HDHPs (a.k.a. "low-premium" health plans) as a primary coverage vehicle, enabling more people to open accompanying save/spend/invest accounts - HSAs. The increase in individual HSA accounts to more than 20 million and the growing trend of consumers paying out-of-pocket for medical expenditures are driving financial institutions to evolve. Insurers, banks, investment managers and card companies are seeking out new platforms, systems, practices and strategies to serve employers and consumers in their new healthcare spend/save/invest needs.
"Universal coverage programs could significantly change the way Americans navigate and manage healthcare, leading consumers to require new financial accounts and tools to effectively spend/save/invest funds related to healthcare services," said Kirsten Trusko, practice lead of the BearingPoint's Banking Insurance Group. "As they enter unfamiliar territory, financial institutions across the country will depend on new platforms and systems to support the products, services and tools developed for consumers." The Company's views on the potential impact of universal healthcare program adoption, and therefore, multiplied HDHPs and HSAs include the following:
* Insurance Companies: A high percentage of the approximately 40 million uninsured Americans could be added to the commercial health insurance infrastructure, which is currently spending 30 percent of its revenue on administration due to outdated systems, poor interoperability and manual processes. Health plan providers may need to invest in revamped systems and processes to support the potential growth from the addition of 20 to 40 million more currently uninsured consumers.
* Health Providers: Traffic flow in the emergency room (ER) could become more manageable as additional people become insured, thus seeking primary care through traditional options rather than overusing ERs for non-urgent care. This could result in a reduction of write-offs for accounts receivable by hospitals and other health providers. Additionally, the increased "out-of-pocket" payments associated with traditional and HDHP plans could raise the need for real-time access to eligibility, co-pay, deductible status and pricing at the point of care.
* Banks: HDHPs and HSAs are already experiencing growth among the insured and are estimated to reach more than 30 percent of the commercially insured population by 2012. Add to that the 20 to 40 million Americans who could be entering the healthcare system from the uninsured ranks and the number of HDHPs and HSAs could climb. Banks and/or investment managers could expect new deposits in HSAs to grow to more than $200 billion in the next five years, creating far greater consumer need for streamlined methods of information access, spending, saving and health financial planning.
* Card Networks: Current 2012 estimates for healthcare spending are $4 trillion each year, according to the National Coalition on Healthcare. The volume of data and money clearing HSAs and related accounts will raise new requirements for security, fraud, data types/formats, timing and access to effectively serve consumers, providers, carriers and other stakeholders. Networks may work to assure systems (current or new) can accommodate industry changes and growth.
* Investment Banks: Creators of HSAs have referred to them as 401(k)s or IRAs for health. With the potential for more than $200 billion in new consumer deposits by 2012, investment managers will be overseeing more money and customers. However, while investment managers handling retirement funds are typically managing funds held until a retirement date, HSA funds may need to be accessed regularly or early in the event of medical need. Therefore, investment banks will need transactional capabilities beyond traditional investment platforms and may seek partnerships or acquisitions to secure them.
* Consumers: 87 percent of employers will offer consumer-directed healthcare accounts in the next years (including HSAs) with 50 percent of the HSA employers contributing money into these accounts. In order to navigate these new products, consumers will need tools to: 1) understand and compare quality and costs for healthcare services and 2) plan what they will need to save/spend/invest on healthcare, now and into retirement.
Along with its in-depth market forecasts, BearingPoint has also developed comprehensive financial and technology models to help financial services companies understand and prepare for the possible changes in the healthcare marketplace that could result from the implementation of universal health coverage. Additional information about BearingPoint's services and perspectives is available at www.BearingPoint.com.
About BearingPoint, Inc.
BearingPoint, Inc. (NYSE: BE) is one of the world's largest providers of management and technology consulting services to Global 2000 companies and government organizations in 60 countries worldwide. Based in McLean, Va., the firm has more than 17,000 employees focusing on the Public Services, Financial Services and Commercial Services industries. BearingPoint professionals have built a reputation for knowing what it takes to help clients achieve their goals, and working closely with them to get the job done. Our service offerings are designed to help our clients generate revenue, increase cost-effectiveness, manage regulatory compliance, integrate information and transition to "next-generation" technology. For more information, visit the company's Web site at www.BearingPoint.com.
-------------------------------------------
VeriChip Corporation (NASDAQ: CHIP)
VeriChip Corporation closed at $2.10 Monday, trading 2,700 shares.
Company News- February 12, 2008: VeriChip Corporation Protects More Than One Million Infants in 2007
VeriChip Corporation ("Company") (NASDAQ: CHIP), a provider of Radio Frequency Identification (RFID) systems for healthcare and patient-related needs, announced earlier today that Xmark's infant protection systems, led by systems sold under the HUGS brand, protected more than one million infants born in hospitals in 2007. Xmark is a wholly owned subsidiary of VeriChip.
Daniel A. Gunther, President and CEO of Xmark, said, "Now more than ever, hospitals value the security our infant protection systems bring to their labor and delivery wards. As the leader in this industry, we are proud to protect hospitals' smallest and most vulnerable patients. We see sustained growth of this business in 2008 and beyond as we continue to expand our reach throughout North America and other parts of the world where these systems are less common yet no less important." Xmark's infant protection systems are designed to prevent infant abductions and inadvertent child mismatching in hospitals. The main component of the systems is a wearable RFID tag that is assigned to child and mother following birth. Monitors positioned throughout the hospital detect the integrity of the tags and location of the child. If a newborn is removed from the ward, if the tag is lifted from the baby's skin or if the ankle strap is compromised, the system immediately triggers an alarm, alerting hospital security to the situation. Xmark infant protection systems also protect against mismatching events by affixing matching RFID tags to mother and child. If the mother is given the wrong child, the RFID tag detects the mismatch and activates an audible alarm.
For more information on Xmark's products, please contact 1-866-55-XMARK or email sales@xmark.com. Additional information can be found online at www.xmark.com.
About Xmark
Based in Ottawa, Ontario, Xmark is a wholly owned subsidiary of VeriChip Corporation. For over 25 years, Xmark Corporation has provided RFID solutions to identify, locate, and protect people and assets in healthcare environments. Its market-leading infant protection, wander prevention, personal duress, and asset tracking applications are trusted by over 5,000 healthcare institutions worldwide to keep individuals safe.
Xmark products are installed and serviced through an international network of authorized dealers, backed by a dedicated technical services department at Xmark. All aspects of Xmark's business are certified to the ISO 9001 quality standard.
About VeriChip
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells RFID systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. The Company recently began marketing its VeriMed(TM) Patient Identification System, a passive RFID system for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the U.S. FDA.
For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com.
-------------------------------------------
The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BusinessNewsNow.US has not been compensated for services rendered; BusinessNewsNow.US is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers, go to http://www.businessnewsnow.us/ (disclaimers)
CONTACT: BusinessNewsNow.US e-mail: info@businessnewsnow.us/ WWW: http://www.businessnewsnow.us/
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2008 M2 COMMUNICATIONS LTD
**********************************************************************
As of Friday, 02-08-2008 23:59, the latest Comtex SmarTrend? Alert, an automated pattern recognition system, indicated a DOWNTREND on 11-16-2007 for BE @ $4.17.
For more information on SmarTrend, contact your market data provider or go to www.mysmartrend.com
SmarTrend is a registered trademark of Comtex News Network, Inc. Copyright ? 2004-2008 Comtex News Network, Inc. All rights reserved.
-0-
Businessnetwire.us: Arthritis Sufferers Take Note: Stock News You Can Use
New York, NY, Feb 12, 2008 (M2 PRESSWIRE via COMTEX) -- HealthSonix, Inc. (OTC: HSXI); Exactech, Inc. (NASDAQ:EXAC); POZEN Inc. (NASDAQ: POZN); Protalex, Inc. (OTCBB: PRTX)
BusinessNetWire is an affiliate of Stock Profiler.US. Sign up Today for Your Free Stock and Updated News Subscription at http://www.stockprofiler.us Companies who want to broadcast their progress are welcome to contact Stockprofiler.US, LLC at 603-621-9420.
-------------------------------------------
HealthSonix, Inc. (OTC: HSXI)
HealthSonix, Inc. closed at $0.12 Monday, trading 176,025 shares.
Company News- February 11, 2008: HealthSonix Gives Green Light for Production of the enSonix Medical Device
HealthSonix Inc. (OTC: HSXI) (FRANKFURT: H7S) announced yesterday that it is has approved the final sample of its second generation enSonix medical device. Shipments of finished product are expected to commence in the second quarter.
The enSonix personal treatment device has been registered and cleared with the United States, Food and Drug Administration (FDA), and has been designated as a class1 device, the safest classification for medical devices. It has been indicated for pain reduction and muscle relaxation.
"With this new medical device, we offer our customers affordable, effective arthritis pain relief without side effects. Patients can use it in the comfort of their own homes. The enSonix therapy is especially effective when used in combination with the most popular pain relievers. There is an incremental therapeutic benefit when you combine therapies," said Dieter Doederlein, Vice President of Corporate Development. "Arthritis is still the number one cause of chronic pain in North America and the HealthSonix breakthrough medical technology is very timely as the population segment most susceptible to arthritis will double over the next 20 years." The sound pressure waves generated by the enSonix medical device are believed to work in three ways: they stimulate mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control theory of pain); they create an exercise effect in the muscles, which encourages the production and release of endorphins, the body's natural pain killers; and increase in blood circulation.
"Our objective is very clear; deliver as much product this year as we can to fulfill significant order back log that has been created over the past 12 months and to focus on development and expansion of distribution and sales channels for all of our consumer products," added Mr. Doederlein.
About HealthSonix, Inc.
HealthSonix, Inc. (OTC:HSXI)(FWB:H7S) is a publicly traded research oriented medical technology company that develops and markets medical devices and healthcare products for institutional and consumer use. The company's patent pending medical devices deliver sound pressure waves to the human body for relief of pain and other musculoskeletal conditions. The focus is on arthritis, athletic injuries and conditions where acute or chronic pain is the cardinal symptom.
More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
-------------------------------------------
Exactech, Inc. (NASDAQ:EXAC)
Exactech, Inc. closed at $24.82 Monday, trading 76,800 shares.
Company News- February 11, 2008: Exactech, Inc. Announces Year End Earnings and Conference Call
Exactech, Inc. (NASDAQ: EXAC), a developer and medical device manufacturer specializing in bone and joint restoration products for hip, knee, shoulder and spine, including biologic materials, announced earlier today it will release fourth-quarter and 2007 year-end earnings on Thursday, February 28, after the market closes.
Exactech will hold a conference call with CEO Dr. William Petty and key members of the management team on Friday, February 29 at 11:00 am Eastern. The call will cover the company's year-end and fourth quarter results. Petty will open the conference call and a question-and-answer session will follow.
To participate in the call, dial 800-762-8779 any time after 10:50 a.m. Eastern on February 29. International and local callers should dial 480-248-5081. While in conference, if callers should experience any difficulty or require operator assistance, they can press the star button (*) followed by the (0) button. This will call an operator to the line.
A live webcast of the call will be available at http://viavid.net/dce.aspx?sid=00004A51. A podcast will be available approximately 15 minutes after the event ends and can be accessed at http://viavid.net/mp3/00004A51.mp3. Both will be archived for approximately 90 days.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech's orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States and Australia, in addition to more than 25 countries in Europe, Asia and Latin America. Additional information about Exactech, Inc. can be found at http://www.exac.com.
-------------------------------------------
POZEN Inc. (NASDAQ: POZN)
POZEN Inc. closed at $12.39 Monday, trading 183,500 shares.
Company News- February 12, 2008: POZEN Announces February 26, 2008 Webcast of Fourth Quarter and Full Year 2007 Results
POZEN Inc. (NASDAQ: POZN), announced earlier today that it will release fourth quarter and full year 2007 results on February 26, 2008, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m. Eastern Time with a discussion by POZEN management of the earnings and business results. The webcast can be accessed on POZEN's website at www.pozen.com and will be archived and available for replay. The fourth quarter and full year 2007 earnings release will be accessible in the News section of POZEN's website.
About POZEN Inc. (NASDAQ: POZN)
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline for the proposed product candidate Treximet which is currently under review by the United States Food and Drug Administration for the acute treatment of migraine, and with AstraZeneca for the proposed product candidate PN 400 for conditions such as osteoarthritis and rheumatoid arthritis in patients who are at risk for developing NSAID-associated gastric ulcers. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.
-------------------------------------------
Protalex, Inc. (OTCBB: PRTX)
Protalex, Inc. closed at $1.10 Monday, trading 10,000 shares.
Company News- February 12, 2008 Protalex to Present at The 10th Annual BIO CEO & Investor Conference
Protalex, Inc. (OTCBB: PRTX) announced earlier today that Steven H. Kane, President and Chief Executive Officer of Protalex, Inc., will give a corporate presentation at The 10th Annual BIO CEO and Investor Conference being held February 11-13, 2008 at The Waldorf-Astoria in New York City.
Mr. Kane is scheduled to speak on Wednesday, February 13, 2008 at 3:30 PM Eastern Time in the West Foyer. The presentation and additional company information can be accessed on the company's web site at www.protalex.com.
About Protalex, Inc.
Protalex, Inc. is a biotechnology company engaged in the development of a new class of drugs for the treatment of Rheumatoid Arthritis (RA), Idiopathic Thrombocytopenic Purpura (ITP), and a host of other autoimmune disorders. Additional information about Protalex, Inc. can be found at www.protalex.com.
-------------------------------------------
The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BusinessNetwire.US affiliates has not been compensated for services rendered; BusinessNetwire.US affiliates is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers, go to http://www.businessnetwire.us) (disclaimers)
CONTACT: BusinessNetwire.US e-mail: info@ businessnetwire.us WWW: http://www.businessnetwire.us/
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2008 M2 COMMUNICATIONS LTD
**********************************************************************
As of Friday, 02-08-2008 23:59, the latest Comtex SmarTrend? Alert, an automated pattern recognition system, indicated an UPTREND on 01-15-2008 for POZN @ $13.01.
For more information on SmarTrend, contact your market data provider or go to www.mysmartrend.com
SmarTrend is a registered trademark of Comtex News Network, Inc. Copyright ? 2004-2008 Comtex News Network, Inc. All rights reserved.
-0-
NEWS NEWS NEWS NEWS NEWS NEWS
HealthSonix Gives Green Light for Production of the enSonix Medical Device
IRVINE, Calif., Feb 11, 2008 (BUSINESS WIRE) -- HealthSonix Inc. (OTC:HSXI) (FRANKFURT:H7S) today announced that it is has approved the final sample of its second generation enSonix medical device. Shipments of finished product are expected to commence in the second quarter.
The enSonix personal treatment device has been registered and cleared with the United States, Food and Drug Administration (FDA), and has been designated as a class1 device, the safest classification for medical devices. It has been indicated for pain reduction and muscle relaxation.
"With this new medical device, we offer our customers affordable, effective arthritis pain relief without side effects. Patients can use it in the comfort of their own homes. The enSonix therapy is especially effective when used in combination with the most popular pain relievers. There is an incremental therapeutic benefit when you combine therapies," said Dieter Doederlein, Vice President of Corporate Development. "Arthritis is still the number one cause of chronic pain in North America and the HealthSonix breakthrough medical technology is very timely as the population segment most susceptible to arthritis will double over the next 20 years."
The sound pressure waves generated by the enSonix medical device are believed to work in three ways: they stimulate mechanoreceptors in the skin, which in turn communicate with the brain and block pain messages from getting through (gate control theory of pain); they create an exercise effect in the muscles, which encourages the production and release of endorphins, the body's natural pain killers; and increase in blood circulation.
"Our objective is very clear; deliver as much product this year as we can to fulfill significant order back log that has been created over the past 12 months and to focus on development and expansion of distribution and sales channels for all of our consumer products," added Mr. Doederlein.
HealthSonix, Inc. (OTC:HSXI)(FWB:H7S) is a publicly traded research oriented medical technology company that develops and markets medical devices and healthcare products for institutional and consumer use. The company's patent pending medical devices deliver sound pressure waves to the human body for relief of pain and other musculoskeletal conditions. The focus is on arthritis, athletic injuries and conditions where acute or chronic pain is the cardinal symptom.
More information regarding HealthSonix, Inc. and its products and services can be found on the World Wide Web at: www.HealthSonix.com or by calling the company at 1-877-622-2121.
Note: A number of statements contained in this news release are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
SOURCE: HealthSonix Inc.
but we heard something...
paul is a liar, why?
NEWS OUTTA RIGHT NOW
SpeechSwitch, Inc. Announces Change to Company Board of Directors
MATAWAN, NJ, Feb 07, 2008 (MARKET WIRE via COMTEX) -- SpeechSwitch, Inc. (OTCBB: SSWC), a leader in speech recognition technology, today announced that it had accepted the resignation of Mr. Jerry Mahoney as Non-Executive Chairman of the Company and will appoint Mr. Mark Meller as a new member of the Board of Directors.
Mr. Meller is currently CEO and a director of both MM2 Group, Inc. and Trey Resources, Inc. From October 2004 until January 2007, he was also Chief Executive Officer and Director of Deep Field Technologies, Inc. From August 2005 until August 2006, Mr. Meller served as Chief Executive Officer of iVoice Technology, Inc. Mr. Meller was also previously, for over 15 years, Chief Executive Officer of Bristol Townsend & Co., Inc., a New Jersey based consulting firm providing merger and acquisition advisory services to middle market companies. Mr. Meller is an attorney and a member of the Bar of the State of New York.
"I want to thank Mr. Mahoney for his assistance on the board and look forward to keeping a close working relationship with him in the future. I welcome Mr. Meller, who will bring a wealth of experience and expertise to SpeechSwitch, and am extremely pleased that he has agreed to join us," said Bruce Knef, President and Chief Executive Officer of SpeechSwitch. "The board will play a vital role in advancing SpeechSwitch in the coming months."
About SpeechSwitch, Inc:
SpeechSwitch previously was a wholly owned subsidiary of iVoice, Inc. prior to the spin-off from iVoice that was completed in August 2005 as a special stock dividend distribution to iVoice shareholders. SpeechSwitch, Inc. was incorporated in New Jersey on November 10, 2004 as a wholly owned subsidiary of iVoice, Inc. It is engaged in the design, manufacture, and marketing of specialized telecommunication equipment. Our products use standard open-architecture PC platforms and Microsoft Windows operating systems, thereby facilitating the rapid adoption of new PC-based technologies while reducing overall product costs. We concentrate our product development efforts on software, rather than hardware, because we believe that the most efficient way to create product value is to emphasize software solutions that meet customers' needs. We have traditionally used standard PC-related hardware components in our products, in part, to limit our need to manufacture components. Our manufacturing operations consist only of the installation of our proprietary software and, if required, a voice board, into a fully assembled PC system which we obtain from several different vendors. The Company obtains system components such as PCs, circuit boards, application cards, fax boards, and voice boards from various suppliers. Our flagship product is our Speech-enabled Auto Attendant product. The Auto Attendant engages callers in a natural language dialog and is ready to transfer a caller to an extension for the party the caller is trying to reach at any time. Callers can interrupt the Auto Attendant at any time by barging in on the prompts and simply saying the name of the person or department they wish to speak to.
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated" and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to SpeechSwitch, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language. www.speechswitch.com
Contact:
Bruce Knef
SpeechSwitch, Inc.
750 Highway 34
Matawan, New Jersey 07747
Tel: 732-441-7700 "Just Say My Name"
Fax: 732-441-9895
www.speechswitch.com
brucek@speechswitch.com
SOURCE: SpeechSwitch, Inc.
CONTACT: http://www.speechswitch.com
mailto:brucek@speechswitch.com
Copyright 2008 Market Wire, All rights reserved.
-0-
SUBJECT CODE: Computers and Software:Software
Telecom:Telecommunication Equipment
Telecom:Telecommunication Services
Computers and Software:Hardware
okay it isn't so new, but the side (http://www.zingiberrx.com/) looks very nice and professional!
let's rock... thursday=newsday!!!
HSXI is alive and well.
let's rock!
FFBU is alive and well.
We will see where the pps goes
sounds good
hopefully the pps get on 0.01
nice news
why they wouldn't say, if they take a deal?
u smell some news? u know something or is it only your opinion...
i don't know, why the last news aren't published on the official website from MMGP!?
hi. i've written yesterday an e-mail to the CEO.
no answer until now...
i think, something is going wrong! or not?
don't forgott the great news who was published this month!!!!
MM2 Group Closes Sale for New Fish Oil Product
Transaction Valued at Over $96,000
LIVINGSTON, N.J., Dec 11, 2007 /PRNewswire-FirstCall via COMTEX/ -- MM2 Group, Inc. (OTC Bulletin Board: MMGP) announced today that its wholly-owned subsidiary, Genotec Nutritionals, Inc., a New York based nutraceutical company which generates its sales from the distribution of its branded products and through custom formulations for several large strategic partners, has closed on a large order for a new product featuring high potency odorless fish oil and Coenzyme Q10 (CoQ10).
The transaction is valued at over $96,000. The order is expected to be the first of two orders from this customer, with the second order coming within the next 120 days.
Fish oil is known for being rich in unsaturated fatty acids and provides essential Omega-3 fatty acids (EPA and DHA). Fish oil may help reduce or inhibit risk factors involved in cardiovascular disease, cognitive decline, macular degeneration, as well as inflammatory and immune disorders. Omega-3 fatty acids also help prevent menopausal symptoms, promotes better circulation and neural development, and lowers cholesterol and triglycerides.
Coenzyme Q10 (CoQ10) is produced by the human body and is necessary for the basic functioning of cells. CoQ10 plays a key role in producing energy in the mitochondria, the part of a cell responsible for the production of energy in the form of ATP. CoQ10 levels are reported to decrease with age and to be low in patients with some chronic diseases such as heart conditions, muscular dystrophies, Parkinson's disease, cancer, diabetes, and HIV/AIDS. Some prescription drugs, like statins, may also lower CoQ10 levels.
Mark Meller, CEO of MM2 Group, stated, "We are pleased to announce the closing of this sale. While the size is small relative to some of the other transactions we've recently announced, I felt it was important to communicate to our shareholders that we are doing business every day. We are not just looking for home runs, but also singles and doubles. We recently announced net income of $951,855 for our fiscal first quarter, and we secured a large $1.1 million order for our omega-3 fish oil sofgels. We have positioned Genotec to grow into a very large company in the near future."
About MM2 Group, Inc.
MM2 Group is involved in the acquisition and build-out of dietary supplement and nutraceutical companies. The company's growth strategy is to acquire firms in this extensive and expanding but highly fragmented segment as it seeks to create substantial value for shareholders. For more information, contact MM2 Group CEO Mark Meller at (732) 290-0019 or by e-mail at meller@mm2group.net or Jerry Mahoney at jerrym@mm2group.net.
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, regarding among other things our plans, strategies and prospects -- both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements contained in this news release may be identified by the use of forward-looking words such as "believe," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," and "potential," among others. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements attributable to MM2 Group, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.
StandoutStocks.com: Standoutstocks.com Stocks that Standout for Friday December 21st -- SLND, AWYI, FSKM, PPMC, SNRS, ONMC
Dec 21, 2007 (M2 PRESSWIRE via COMTEX) -- -- StandoutStocks.coms "Stocks that Standout Alert" this Morning are: Solar Night Industries (PINKSHEETS: SLND), Ariel Way, Inc. (OTC Bulletin Board: AWYI), Firesky Media Corp. (Pink Sheets: FSKM), Purchase Point Media Corp.(OTCBB: PPMC), Sunrise Consulting Group, Inc. (Pink Sheets: SNRS) and OMNINET MEDIA.COM, INC. (PINKSHEETS: ONMC).
Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Solar Night Industries (PINKSHEETS: SLND - http://finance.yahoo.com/q?s=SLND.PK)
December 20th, 2007-- Solar Night Industries (PINKSHEETS: SLND), a renewable energy company formed to accelerate the adoption of Modern Energy Solutions, was featured recently in an article on Green Options. The full article can be viewed at http://sustainablog.org/2007/12/05/solar-night-industries-launches-moder n-energy-plan-web-application/.
Senior Editor for Green Options, Jeff McIntire-Strasburg, explained the Modern Energy Plan, "Because renewable adoption is still in a relatively early phase, information is key to bringing these technologies into the mainstream. SNI created a simple, elegant option for providing that necessary information. Take a look at the sample plan they provide, and, if you're seriously considering renewables for your home or business, give the system a spin. I know other tools like these are on the horizon, and a healthy competitive environment will exist in this space shortly. At the same time, I think SNI's set a high bar for competitors." The sample plan can be accessed at: (https://system.netsuite.com/c.474300/MEP_Sample_Residential.pdf).
About Solar Night Industries, Inc.
Solar Night Industries, Inc. is a national Modern Energy Company that enables residential and commercial energy users to implement cost-effective, renewable energy solutions that help them reduce their dependence on traditional energy sources, reducing Co2 emissions. Solar Night Industries, Inc. is based in St. Louis, Missouri (USA). For more information, please visit http://www.SolarNightIndustries.com
Ariel Way, Inc. (OTCBB: AWYI - http://finance.yahoo.com/q?s=AWYI.ob)
December 19th, 2007-- Ariel Way, Inc. (OTC Bulletin Board: AWYI) announced today that the Company has signed a Memorandum of Understanding with Mason Media Group, LLC, (MMG) a Washington, D.C. based holding company, (www.masonmediagroup.com), that develop, produce, and provide technical services to the broadcast, cable, and film industry with a primary focus on Sports and Entertainment. MMG is also a provider of focused advertising, marketing, entertainment, and audiovisual content capitalizing on the New Media Revolution. Per the agreement, MMG will become a strategic partner to Ariel Way and MMG's top professionals will support Ariel Way's executives with its Digital Signage Business Plan.
Arne Dunhem, Ariel Way president and CEO, said, "We are excited to have Todd Mason and his group as a strategic partner and to have his highly skilled professionals to work with us. They have a terrific experience and capabilities in creating content and HDTV productions that would benefit our advertising clients for our strategy of building a state-of-the-art highly secure Digital Signage Network."
Todd Mason, CEO of MMG, said, "We are looking forward to be part of Ariel Way's Digital Signage strategy. Besides HDTV productions, we believe that we can provide support with focused advertising, marketing, entertainment, and audiovisual content."
About Ariel Way, Inc.
Ariel Way, Inc., ("Ariel Way" or the "Company"), is a technology and services company for highly secure global communications, multimedia and digital signage solutions and technologies. The Company is focused on developing innovative and secure technologies, acquiring and growing profitable advanced technology companies and global communications service providers and creating strategic alliances with companies in complementary product lines and service industries.
More information about Ariel Way can be found on the web at http://www.arielway.com.
Mason Media Group, LLC
Mason Media Group is a holding company, with a mission to expand and invest in unique, top-tier communication and entertainment companies that are revolutionizing the way that people connect and receive information. Mason Media Group identifies new markets and growing companies that build value and equity for its investors and customers. Mason Media Group is poised to become the premier provider of focused advertising, marketing, entertainment, and audiovisual content capitalizing on the New Media Revolution.
MMG companies work with entertainment, political/advocacy, and corporate clients to develop, craft and distribute their message. MMG companies are composed of highly creative and experienced individuals who are leaders in their industry and leverage the latest in new media technology.
Firesky Media Corp. (Pink Sheets: FSKM - http://finance.yahoo.com/q?s=FSKM.pk)
December 18th, 2007-- Firesky Media Corp. (Pink Sheets: FSKM) http://www.fireskymedia.com, announced today that it has signed a letter of intent to acquire Sky Electronics, Inc. ("Sky") http://www.skyelec.com. Sky's revenue for 2007 will be approximately $18.5 million; they are profitable and have seen sales grow 52% since 2004. Firesky will acquire Sky for $2.5 million in cash and 38% of Firesky common stock.
Sky is a distributor of OEM original products of network gear and server products from the world's leading manufacturers. Through its network of global sources Sky distributes new OEM original packaged products without franchise distribution costs, which provides Sky's customers with access to OEM products at a reduced cost as well as with same day shipping. As a result, Sky has significant margin opportunities and a large customer base.
"Sky has demonstrated its ability to distinguish itself as a nationwide leader in providing its customers with attractive pricing and delivery of innovative technologies in this rapidly growing market segment of OEM packaged products," said John Harris, incoming Firesky President and Chief Executive Officer. "Solution providers are increasingly turning to alternative sources and specialty distributors which is making this market segment extremely attractive. Sky is poised to become a significant leader in this multi-billion market."
"Sky's future is focused on providing our Value Added Reseller customer base with superior pricing, service, and new OEM product solutions," said Dan Rickabus, CEO of Sky. "The acquisition of Sky by Firesky will allow Sky's management team to focus solely on this goal and provide a terrific platform and opportunity to consolidate this fairly fragmented industry segment."
Once the acquisition is complete, Sky will continue to have full autonomy over its day to day operations, with Sky CEO Dan Rickabus joining the Firesky Board of Directors. In addition, Firesky plans to make additional acquisitions of other similar companies. The Company also plans to change its name during the fourth quarter.
About Sky Electronics, Inc.
Sky is a non-franchised stocking distributor of OEM original products. Through its network of global sources and manufacturer's products, Sky provides its customers with new OEM original packaged products without franchise distribution costs, with greater flexibility in policies and procedures, and access to millions of products and same day shipping. Sky is recognized as the low cost distributor of new packaged products, without sacrificing quality, technology or on-time delivery.
About Firesky Media
Firesky Media Corp., currently based in Irvine, California, is focusing on the electronic hardware and computer component industry. As the Company nears completion of its restructuring activities, the company is in the process of reorganizing its management team and board of directors. The Company plans to change its name during the fourth quarter.
More information about Firesky Media can be found at: http://www.fireskymedia.com.
Purchase Point Media Corp.(OTCBB: PPMC - http://finance.yahoo.com/q?s=PPMC.ob)
December 19th, 2007-- PURCHASE POINT MEDIA CORP. Files Financials
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
PERIOD ENDING 30-Sep-07 30-Jun-07 31-Mar-07 31-Dec-06
Total Revenue 2,141 - - -
Cost of Revenue 1,704 - - -
Gross Profit 436 - - -
Operating Expenses
Research Development - - - -
Selling General and Administrative 1,736 272 27 35
Non Recurring - - - -
Others - 0 0 0
Total Operating Expenses - - - -
Operating Income or Loss (1,300) (273) (27) (36)
Income from Continuing Operations
Total Other Income/Expenses Net 4 2 - -
Earnings Before Interest And Taxes (1,296) (271) (27) (36)
Interest Expense 56 21 20 19
Income Before Tax (1,352) (293) (47) (55)
Income Tax Expense (128) - - -
Minority Interest - - - -
Net Income From Continuing Ops (1,224) (293) (47) (55)
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income (1,224) (293) (47) (55)
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares ($1,224) ($293) ($47) ($55)
Sunrise Consulting Group, Inc. (Pink Sheets: SNRS - http://finance.yahoo.com/q?s=SNRS.pk)
December 18th, 2007-- As an Internationally recognized business leader, Raymond Y. Chin brings more than 20 years of leadership, management, and marketing experience to the organization. Raymond is definitely the impeccable leader for Sunrise Consulting Group, Inc. (Pink Sheets: SNRS) and his extensive leadership and vision for the company complements the efforts that he has made in helping the company go public. His strong management experience will help shape Sunrise Consulting Group, Inc. to become an international conglomerate with mergers and acquisitions.
Raymond has issued this statement: "I am extremely strong in the field of marketing and marketing overseas especially in Hong Kong & China (including Taiwan). I love to do mergers and acquisitions. I grew up in the US and I've been working on my business overseas for over ten years in Hong Kong & China. I am extremely fluent in my native tongue Chinese (Mandarin and Cantonese).
Since China has been admitted to the WTO, there are many US multinational firms which are very interested in going into Hong Kong and China for business. There are also barriers for many Chinese firms who want to do business with oversea companies. I will be an ideal candidate in breaking in the barriers between US and China. I have lived in the US since I was ten and I understand both cultures very well."
Raymond has been President for many companies and has served as President & CEO for Sunrise Financial & Insurance Services Inc., Philadelphia, PA: for more than 10 years. As a graduate from Drexel University with a BS degree in Business & Administration in Marketing & Economics, Philadelphia, PA (1982), Raymond is more than qualified to be at the helm of this organization.
OMNINET MEDIA.COM, INC. (PINKSHEETS: ONMC - http://finance.yahoo.com/q?s=ONMC.pk)
December 19th, 2007-- OMNINET MEDIA.COM, INC. (PINKSHEETS: ONMC), soon to be AQUAGOLD International, Inc., announces today that the merger between the two companies is now completed with all contracts signed and the merger documents being filed today with both the State of Nevada and NASDAQ.
Upon completion of the filing of the final merger documents with both the State of Nevada and NASDAQ, OMNINET MEDIA.COM, INC. will immediately file the official name change to AQUAGOLD International, Inc. and apply for a new CUSIP number. This entire process should take about 2 weeks to be completed.
Mr. Manuel Da Silva, President & CEO of AQUAGOLD International, Inc., commented: "With the finalization of the merger, AQUAGOLD is now one step closer to becoming a fully reporting public company, as shipments of our premium spring water continue to arrive in China. Now we are able to begin releasing details of our contracts and recent material events to the investment community."
Mr. Da Silva continued, "Within the next 10 to 14 days, we will finally be one company, operating with one goal and realizing one dream to successfully launch the AQUAGOLD-branded premium Spring Water into the China Market, satisfying the Chinese consumers' demands and meeting or exceeding our shareholders' investment expectations of share value and ROI."
About AQUAGOLD International, Inc.
"AQUAGOLD" branded premium Canadian Spring Water is presently being shipped into China. In 2005, sales of bottled water in China experienced strong growth of 16% (liters) and 15% (RMB/$) to reach 11.2 billion liters and RMB24.1 billion or $3.17 Billion in volume and current value terms. The estimates on AQUAGOLD's China contract alone exceed $500 Million in revenues, however how much in excess will follow in the near future resulting from ongoing marketing activities such as the upcoming trade show in Shanghai, China over the coming few weeks.
Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.
About StandoutStocks.com
StandoutStocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.
Standout Stocks email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout Stocks Report home page at www.standoutstocks.com and select the "join now" button.
Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence. StandOutStocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. StandOutStocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. StandOutStocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), standoutstocks.com is owned and operated by StandOutStocks.com. Neither StandOutStocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since StandOutStocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in StandOutStocks.com statements and opinions and such statements and opinions cannot be considered independent. StandOutStocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. StandOutStocks.com services are often paid for using free-trading shares. StandOutStocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full www.standoutstocks.com/disclaimer.htm.
CONTACT: StandoutStocks.com e-mail: info@StandouStocks.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2007 M2 COMMUNICATIONS LTD
-0-
what's going on? no volume, no news no nothing
patience is the most important in this stock! it would be rise up next you...
in this moment you have to buy at a low price 0.009 and sold it at 0.013...
if you live in switzerland, like me, you can't do this beacause of the taxes...